3D-QSAR analysis of oxadiazole substituted α-isopropoxy phenylpropionic acids as PPAR-α & PPAR-γ agonists

Indian Drugs

Volumn 40, Issue 11, 2003, Pages 627-635

  Kumar, S L ^a   Rao, P H ^a   Sambasivarao, S V ^a   Gupta, A K ^a   Arockia, B M ^a   Kaskhedikar, S G ^a  

^a SHRI G S INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

3D QSAR; Antihyperglycemic; Isopropoxy phenylpropionic acid analogs; PPAR ; PPAR

Indexed keywords

HYPERGLYCEMIC AGENT; OXADIAZOLE DERIVATIVE; PHENYLPROPIONIC ACID DERIVATIVE;

ARTICLE; CORRELATION ANALYSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PARAMETER; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STATISTICAL ANALYSIS; THERMODYNAMICS; VALIDATION PROCESS;

EID: 10944250542     PISSN: 0019462X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Reaven G.M., Role of insulin resistance in human disease, Diabetes, 1998, 37, 1595-1607.
2. Porte D. and Schwarte M.W., Diabetes complications: Why is glucose potentially toxic?, Science, 1996, 27, 699-700.
3. Sorbera L.A., Leeson P.A., Martin L. and Castaner J., Farglitazar : Antidiabetic PPARā Agonist, Drugs of Future, 2001, 26, 354-363.
4. Willson T.M., Brown P.J., Sterenbatch D.D. and Henke B.R., The PPARs: From orphan receptor to drug discovery, J. Med. Chem., 2000, 43, 527-549.
5. Goldberg I.J., Diabetic dyslipidemia: Causes & consequences, J. Clin. Endocrine. Metab., 2001, 86, 965-971.
6. Garg A., Treatment of diabetic dyslipidemia, Am. J. Cardio., 1998, 81, 47 B-51B.
7. Brown P.J., Winger D.A., Plunket K.D., Moore L.B., Lewis M.C., Willson J.G., Sundseth S.S., Koble C.S., Wu Z., Chapman J.M., Lehmann J.L. Kliewer S.A. and Willson, T.M., A ureido-thioisobutyric acid (GW-9578) is a subtype selective PPARá agonist with potent lipid-lowering activity, J. Med. Chem., 1999, 42, 3785-3788.
8. Murakami K., Tobe K., Ide T., Mochizuki T., Ohashi M., Akanuma Y., Yazaki Y. and Kadowaki T., Anovel insulin sensetizer acts as a coligand for peroxisome proliferator activated receptor-α (PPAR-α) and PPAR-α: effect of PPAR-γ activation of abnormal lipid metabolism in liver of zucker fatty rats, Diabetes, 1998, 47, 1841-1847.
9. Nomura M., Kinoshita S., Satoh H., Maeda T., Murakami K., Tsunoda M., Miyachi H. and Awano K., (3-substituted benzyl) thiazolidine-2, 4-diones as structurally new Antihyperglycemic agents, Bioorg. Med. Chem. Lett., 1999, 9, 533-538.
10. (a) Brooks D.A., Etgen G.J., Rito C.J., Shuker A., Dominianni S.J., Warshawasky A.M., Ardecky R., Paternity J.R., Tyhonas J., Karanewsky D.S., Kauffman R.F., Brodrick C.L., Oldham B.A., Monrtose-Rafizade C., Winneroski, L.L., Faul M.M. and McCarthy J.R., Design & synthesis of 2-methyl-2{4-[2-(5-methyl-2-aryl oxazole-4-yl) ethoxy] phenoxy} propinoic acid : A new class of dual PPAR α/γ agonists, J. Med. Chem., 2001, 44, 2061-2064.
11. (b) Lohary B.B., Lohary V.B., Bajji A.C., Kalcher S., Poondra R.R.J., Padakanti S., Chakrabarty R., Vikramadityan R.K., Mishra P., Juluri S., Mamidi N.V.S.R. and Rajgopalan R., (-) 3-[4-[2-(phenoxazin-10-yl) ehtoxy] phenyl]-2-ehoxypropionic acid [(-) DRF 2725]: A dual PPAR agonist with potent antihhyperglycemic and lipid modulating activity, J. Med. Chem., 2001, 44, 2675-2678.
12. Manch C., In; Comprehensive Medicinal Chemistry, Vol.4, Pergamon Press, NewYork, 1990, 125-138.
13. Smith H.J. and Williams H., In; Introduction to Principal of Drug Design, JohnWright & Sons Ltd, Bristol, 1983.
14. Liu K.G., Smith J.S., Ayscue A.H., Henke B.R., Lambert M.H., Leesnitzer L.M., Plunket K.D., Willson T.M. and Sterenbatch D.D., Identification of a series of oxadiazole substituted á-isopropoxy phenylpropanoic acids with activity on PPARα, PPARγ & PPARδ, Bioorg. Med. Chem. Lett., 2001, 11, 2385-2388.
15. CS Chem Office, Version 6.0, Cambridge Soft Corporation, Software Publishers Association, 1730 M Street, NW, Suite 700, Washington D.C. 20036(202) 452-1600, USA.
16. Kier L.B., In; Molecular Orbital Theory in Drug Research, Academic Press, New York, 1971, 62.
17. Mansch C. and Leo A., In; Substituent Constants for Correlation Analysis in Chemistry and Biology, John Wiley & Sons, New York, 1979, 48-63.
18. Draper N.R. and Smith H., In; Applied Regression Analysis, John Wiley & Sons, New York, 1966, 193.
19. Chakarvarti S.K., Ajmani S. and Chaturvedi S.C., SMRAILS-A lotus 1-2-3 spreadsheet for stepwise multipie parameter regression analysis applied to QSAR analysis, Ind. J. Pharm. Sci., 1998, 60, 371-374.
20. Kubinyi H., In; QSAR: Mansch Analysis & Related Approaches, Weinheim, New York, 1993, 91.